ARCHIVES

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

This article is from The Cancer Letter archive.

Vol. 33 No. 46 | December 14, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI-Litton Negations On Frederick continue; Staffs Not Worried About Possible GAO Probe

July 15, 1977

Bladder Cancer “Headquarters” Grant Program Seeks Applications For High Priority Research

March 1, 1974

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011

House Completes Committee Lineups

February 18, 1977

Nursing Center Moves Onto Campus

May 9, 1986

NCCS Networker Volume 4 Issue 4, Fall 1990

September 13, 1990